⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
MoonLake Immunotherapeutics Announces Positive Outcome from Type B Meeting with U.S. FDA and Announces Investor Day
globenewswire.com
MLTX
Join Class Action to Recover Losses from MoonLake Immunotherapeutics (MLTX) - Contact Levi & Korsinsky Before December 15, 2025
accessnewswire.com
MLTX
Pomerantz LLP Reminds Shareholders with Losses on their Investment in MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
Contact Levi & Korsinsky by December 15, 2025 Deadline to Join Class Action Against MoonLake Immunotherapeutics(MLTX)
globenewswire.com
MLTX
MLTX DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages MoonLake Immunotherapeutics Investors with Losses in Excess of $100K to Secure Counsel Before Important December 15 Deadline in Securities Class Action - MLTX
accessnewswire.com
MLTX
Levi & Korsinsky Helps Retail Investors SueWallSt Over Alleged Fraud by MoonLake Immunotherapeutics
accessnewswire.com
MLTX
Investors SueWallSt Over MoonLake Immunotherapeutics Stock Drop - Contact Levi & Korsinsky to Join
accessnewswire.com
MLTX
Lost Money on MoonLake Immunotherapeutics (MLTX)? Join Class Action Before December 15, 2025 - Contact Levi & Korsinsky
accessnewswire.com
MLTX
MLTX DEADLINE ALERT: Hagens Berman Alerts MoonLake (MLTX) Investors to Today's Lead Plaintiff Deadline in Securities Class Action
prnewswire.com
MLTX
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – MLTX
businesswire.com
MLTX